The Indian company Natco Pharma Limited has created a flutter in seeking an emergency go-ahead in India for molnupiravir, an investigational antiviral being pursued by Merck & Co., Inc. for the treatment of COVID-19.
Natco’s move is seen as combative by some given that Merck doesn’t appear to have partnered with the Indian firm...






